Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

Authors and Affiliations

1. Stanford University, Palo Alto, CA, USA

   Glenn M. Chertow & Kenneth W. Mahaffey

2. CSL Behring, King of Prussia, PA, USA

   Anna Marie Chang, Mark Heise, Regina Clementi, Jenny Mears & Pierluigi Tricoci

3. Duke University, Durham, NC, USA

   G. Michael Felker, Yuliya Lokhnygina & Myles Wolf

4. CSL Limited, Melbourne, Victoria, Australia

   Elena Velkoska

5. Uppsala University, Uppsala, Sweden

   Bengt Fellström

6. New York University, New York City, NY, USA

   David M. Charytan

7. Harvard Medical School, Boston, MA, USA

   C. Michael Gibson & Paul M. Ridker

8. University of Toronto and University of Alberta, Edmonton, Alberta, Canada

   Shaun G. Goodman

9. University of Sydney, Sydney, New South Wales, Australia

   Meg Jardine

10. University of British Columbia, Vancouver, British Columbia, Canada

    Adeera Levin

11. Mt Sinai Hospital, New York City, NY, USA

    Roxana Mehran

12. Karolinska Institute, Solna, Sweden

    Peter Stenvinkel

13. Hong Kong University, Hong Kong, China

    Angela Yee-Moon Wang

14. University College London, London, UK

    David C. Wheeler

15. Ospedali Riuniti Reggio Calabria, Reggio di Calabria, Italy

    Carmine Zoccali

Corresponding author

Correspondence to Glenn M. Chertow.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions